Navigation Links

Biology Technology

Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets

(PRWEB) December 25, 2014 The report “Service Quality Management and Telco Customer Experience Management Market by Product Type & Provider Type - Global Advancements, Worldwide Forecasts & Analysis (2014-2019)” defines and segments the market with an in-depth analysis and forecasting of revenues. Browse 152 market data tables, 19 figures spread through 221 pages and in-... [Comments]

United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin

SILVER SPRING, Md. , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ) announced today that Medtronic, Inc. (NYSE: MDT ) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed ® II implantable drug infusion system (including a newly developed catheter) for use with United T... [Comments]

PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering

DALLAS and NEW YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per shar... [Comments]

Vermillion Announces Closing of Equity Financing

AUSTIN, Texas , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that the Company closed its previously announced private placement with investors including Oracle Investment Management, Jack W. Schuler , Birchview Fund LLC and several Vermillion directors. Total proceeds were $10.5 m... [Comments]

BioLife Solutions Sets Date for Annual Meeting of Stockholders

BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues  ("BioLife" or the "Company"), today announced that it will hold its 2015 Annual Meeting of St... [Comments]

Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets

(PRWEB) December 23, 2014 “Preparative & Process Chromatography Market by Instrument (Liquid & Gas, HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, Pharmaceutical, Food & Agriculture) - Forecasts to 2019” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current... [Comments]

Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order

St. Louis, Missouri (PRWEB) December 23, 2014 GMO corn cases filed across the United States, and targeting Swiss biotechnology company, Syngenta, are in the process of being consolidated in a Kansas federal court for pretrial proceedings. The consolidated case is In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in the U.S. District Court for the District of Kansas. Management of... [Comments]

Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website

Boston, MA (PRWEB) December 23, 2014 Earlier this year in a June 24 international conference presentation, Dr. James L. Sherley, director of the Adult Stem Cell Technology Center, LLC ( ASCTC ) focused attention on an often overlooked and under appreciated unique property of adult tissue stem cells. His title “Asymmetric Self-Renewal by Distributed Stem Cells: Misunderstood in the Past, Im... [Comments]

SoundConnect Launches Leading Edge Business Communications Webinar Series

BOSTON, MA (PRWEB) December 23, 2014 SoundConnect’s 2015 next generation webinar series is designed to introduce cutting edge communication technology, provide continued education and inform users and partners of platform upgrades. This webinar series demonstrates online communication features and benefits; empowering users in their quest to leverage web conferencing’s most innovative and... [Comments]

Rare Brain Condition Now Eligible for Department of Defense Research Dollars

Bethesda, MD (PRWEB) December 23, 2014 On Friday, December 19, 2014, President Obama signed into law H.R. 83, the Omnibus and Continuing Resolution Appropriations Act of 2015, which for the first time, made hydrocephalus a condition eligible to receive funding through the Congressionally Directed Medical Research Programs (CDMRP) administered by the Department of Defense (DoD). The Hydrocep... [Comments]

ITRA Global Reports Long Island Is Out of Sync With The National Office Market

Long Island, New York (PRWEB) December 23, 2014 According to Ross Selinger, President of Selinger Enterprises , and the Long Island Affiliate of ITRA Global, the national office market continues to be strong, driven by the economy’s slow but steady recovery. This is evidenced by the third quarter’s surprising 3.9% GDP, unemployment decreasing to 5.8% and the strong stock market. Low ener... [Comments]

Medicine Technology

"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients

OTTAWA , Dec. 24, 2014 /CNW/ -   The issue: "Jetfuel Superburn" is being recalled after Health Canada tests confirmed it contains two undeclared amphetamine-like drug substances that pose serious health risks (beta-methylphenethylamine and phenylpropylmethylamine). The distributor, Empire Health Distribution of Terrebonne, Quebec , is recalling the product from retail stores acr... [Comments]

Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke

TIJUANA, Mexico , Dec. 24, 2014  Novastem, a leader in regenerative medicine, announces the treatment of its first patient in its study for ischemic stroke at Clinica Santa Clarita. According to the American Stroke Association, ischemic strokes account for 87 percent of all stroke cases. Novastem continues to enroll qualified patients in the study, entitled "Internal Resea... [Comments]

Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension

DUBLIN , Dec. 24, 2014  Actavis plc (NYSE: ACT ) today confirmed that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for the fixed-dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.   Photo - [Comments]

Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon

HARRISBURG, Pa. , Dec. 24, 2014  Commonwealth Cornerstone Group (CCG) today announced the completion of an $8 million New Markets Tax Credits transaction on Tuesday to help fund the expansion and consolidation of healthcare services provided by Primary Health Network (PHN) in Sharon . PHN is the largest federally qualified health center operating in Penn... [Comments]

TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results

CHENGDU, China, Dec. 24, 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015. Fiscal Year 2015... [Comments]

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study

BUFFALO, N.Y. , Dec. 24, 2014 Kinex Pharmaceuticals announced today that the first patient has been dosed with KX2-361 at Roswell Park Cancer Institute. KX2-361 (KX02), a dual src/pre-tubulin inhibitor, is a small molecule drug that has shown potent inhibitory activity against a broad panel of brain tumor cell lines, including those that are resistant to Temozolomide (T98G),... [Comments]

Soligenix Announces Closing of Public Offering of Units

PRINCETON, N.J. , Dec. 24, 2014 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that on December 24, 2014 it closed its previously announced registered public offering. The Company raised approximately $2... [Comments]

ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC

BEIJING , Dec. 24, 2014  The International Trade Commission (ITC) issued its final decision in the case brought by ResMed (RMD) against BMC Medical. In a notice issued on December 23, the ITC ruled in favor of BMC and found that ResMed's patent on its humidifier was invalid. BMC President, James Xu called the decision a "monumental win". "We are very excited with the I... [Comments]

Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board

SAN DIEGO , Dec. 24, 2014  Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an immuno-oncology therapeutic, announces that Dr. Patrick Soon-Shiong , NantWorks founder, physician scientist and biotechnology entrepreneur, has entered into a definitive agreement... [Comments]

Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association

FLINT, Mich. , Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation's largest independent specialty pharmacy, is proud to announce Jennifer Hagerman , Pharm.D., AE-C, senior director of education and quality at Diplomat, will take office as the president of the Michigan Pharmacists Association on Jan. 1, 2015. The formal induction ceremony will take place Fe... [Comments]

Palatin Completes $20 Million Equity and $10 Million Debt Financings

CRANBURY, N.J. and FARMINGTON, Conn. , Dec. 24, 2014 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, today announced that it has closed on a private placement of 2,050,000 shares of its common stock... [Comments]

(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... 22, 2014 The Center for ... of technical training across the life sciences industry, has ... (SCDM) to provide the organization's members with discounted ... access to the more than 350 sessions across 80 ... 10% off when registering for a public course ...
(Date:12/22/2014)... GenomeDx Biosciences today announced that a new ... genomic test for prostate cancer, was able to predict ... radical prostatectomy without adjuvant therapy. Although rapid metastasis in ... tumor genomics to identify these men who have a ... advance. The study has been published online by ...
(Date:12/22/2014)... TENN (PRWEB) December 22, 2014 Fertility ... Donor Egg Bank USA , a network of ... country. Through this partnership, patients have fast access to ... in vitro fertilization, IVF . Fertility Associates of Memphis ... offer this fertility treatment option. , Dr. William ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3
... Winston-Salem, N.C. -- Wake Forest University has received the ... double the energy production of today,s flat cells at a ... high price to be green," said David Carroll, Ph.D., the ... where the fiber cell was developed. "This device can make ...
... ... the AOL News series, “The Nanotech Gamble,” with advice for nano-product companies on how ... ... series of AOL News articles questioning the oversight of nanotechnology product safety ( ...
... ... role in Merrimack,s acquisition of Hermes Biosciences and partnership with sanofi-aventis , ... Cambridge, MA (PRWEB) April 7, ... and development of novel treatments for cancer and inflammation, today announced that William Sullivan ...
Cached Biology Technology:Wake Forest earns patent for efficient, inexpensive fiber-based solar cells 2nanoTox COO Greg King Advises Nanotech Companies to View Safety Concerns as an Opportunity to Gain Consumer Trust 2nanoTox COO Greg King Advises Nanotech Companies to View Safety Concerns as an Opportunity to Gain Consumer Trust 3Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance 2
(Date:12/24/2014)...  Medical Science Liaisons play a large role in ... medical device industry and key stakeholders, the role of ... as the device industry relies on them to build ... benchmarking firm, Best Practices, LLC, one area where Medical ... by harnessing new technology to enable education. Online conferences ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
(Date:12/22/2014)... Mass , Dec. 22, 2014 /PRNewswire/ -- RXi ... biotechnology company focused on discovering, developing and commercializing ... RNA-targeted technologies, today issued the following open letter ... Cauwenbergh , Dr. Med. Sc. Dear ... days a number of inaccurate statements posted on ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... (OTC BB: completed its Fiscal Year on February ... approximately $12,000,000, an increase of 21% over last year,s ... approximately $1,200,000, an increase of more than 100% over ... of $1,000,000. Sono-Tek will release final audited results in ...
... Ill., March 5, 2012   Process Seals recently ... materials with a new white material specifically developed to ... pharmaceutical, food and beverage, and biotech industries. ... use in O-rings, molded parts and butterfly valve seals ...
Cached Medicine Technology:Sono-Tek Announces Record Year End Results 2Process Seals Develops White Hygienic Sealing Material for Pharmaceutical, Food and Beverage, and Biotech Applications 2